Nuvectis Pharma Inc (NVCT) Financials

$24.49

$0.12 (0.49%)

As on 04-Sep-2026 16:00EDT

Market cap

$799 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

82.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	0.15	--
Cost of Revenue	--	--	--	22.90	19.23	12.89
Gross Profit	--	--	--	-22.90	-19.09	-12.89
Operating Expenses	28.87	27.57	19.85	22.90	19.23	12.89
Operating Profit (EBIT)	-28.87	-27.57	-19.85	-22.90	-19.23	-12.89
Other Income	--	--	--	--	--	--
Profit before Tax	-27.85	-26.44	-19.00	-22.26	-19.09	-12.89
Provision for Tax	--	--	-19.00	0.00	-0.30	0.00
Profit after Tax (Net Income)	-27.85	-26.44	-19.00	-22.26	-18.79	-12.89
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-19.09	-12.89

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	9.08	18.41	9.71	12.20	14.22	-11.01
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	2.91	15.25
Current Liabilities	13.29	13.30	8.89	6.98	6.19	2.42
Total Liabilities	35.67	31.71	18.61	19.19	20.41	6.66

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	--	--	--	--	--	0.82
Current Assets	22.38	31.71	18.61	19.19	20.41	5.83
Total Assets	35.67	31.71	18.61	19.19	20.41	6.66
Total Debt*	--	--	--	--	--	--
Net Current Assets	9.08	18.41	9.71	12.20	14.22	3.41

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-16.01	-12.25	-15.95	-13.56	-9.50
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	29.11	11.65	15.09	27.81	15.25
Net Cash Inflow / Outflow	--	--	--	--	14.25	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.22	-1.21	-0.97	-1.28	-1.28	-1.01
Cash EPS ($)	--	-1.21	-0.97	-1.28	-1.28	-1.01
Adjusted Book Value ($)	--	0.84	0.50	0.70	0.97	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.73	-0.63	-0.92	-0.93	-0.75
Free Cash Flow per Share ($)	--	-0.73	-0.63	-0.92	-0.93	-0.75

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-188.03	-173.41	-168.51	-1,170.17	233.91
ROE (%)	-202.55	-188.03	-173.41	-168.51	-1,170.17	233.91
ROA (%)	-76.49	-105.10	-100.55	-112.45	-138.84	-193.57
EBIT Margin (%)	--	--	--	--	-12,908.72	--
Net Margin (%)	--	--	--	--	-12,608.72	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	-1.00	--	--
EBIT Growth (%)	--	--	9.36	-13.85	-49.17	-37,823.53
Net Profit Growth (%)	-26.19	-39.17	14.65	-18.49	-45.79	-128,760.00
EPS Growth (%)	-8.51	-0.24	0.24	0.00	-0.27	--
Book Value Growth (%)	-51.01	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-6.23	-5.55	-6.53	-5.85	--
Price / Book Value	82.89	8.94	10.86	11.91	7.72	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-7.38	-5.03	-4.58	-5.67	-4.74	--
Close Price ($)	18.39	7.55	5.41	8.34	7.50	--
High Price ($)	29.28	11.52	12.10	18.65	20.92	--
Low Price ($)	5.55	5.33	4.44	7.14	3.08	--
Market Cap ($ Cr)	799.45	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	1.68	2.38	2.09	2.75	3.30	2.41
Quick Ratio	1.68	--	--	--	--	--
Interest Coverage	--	--	--	--	-129.09	-3,223.50

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	0.01	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	45.31	37.68	15.13
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.